KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Income from Continuing Operations (2016 - 2025)

Neogenomics (NEO) has disclosed Income from Continuing Operations for 16 consecutive years, with 9881000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations rose 35.52% year-over-year to 9881000.0, compared with a TTM value of 108025000.0 through Dec 2025, down 37.22%, and an annual FY2025 reading of 108025000.0, down 37.22% over the prior year.
  • Income from Continuing Operations was 9881000.0 for Q4 2025 at Neogenomics, up from 27129000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 75873000.0 in Q2 2021 and bottomed at 49408000.0 in Q1 2022.
  • Average Income from Continuing Operations over 5 years is 21365800.0, with a median of 23509000.0 recorded in 2022.
  • Peak annual rise in Income from Continuing Operations hit 1211.86% in 2021, while the deepest fall reached 895.78% in 2021.
  • Year by year, Income from Continuing Operations stood at 41758000.0 in 2021, then soared by 45.67% to 22687000.0 in 2022, then soared by 36.85% to 14326000.0 in 2023, then dropped by 6.97% to 15324000.0 in 2024, then surged by 35.52% to 9881000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for NEO at 9881000.0 in Q4 2025, 27129000.0 in Q3 2025, and 45092000.0 in Q2 2025.